Q3-2020 FDA Oncology Drug Approvals
Download the Report
The following article is part of a quarterly series highlighting new oncology FDA approvals. Here you will find information surrounding these novel approvals, including trial details, dosing, pertinent toxicity, drug cost, as well as commentary on what the approval may really mean to our oncology community. Each quarter new summaries on recent FDA advances in the world of oncology will be released for review.
To download the report, please fill out the form below.